We are live on ! Find out more
CS

Cannell & Spears Portfolio holdings

AUM $5.1B
1-Year Est. Return 31.77%
This Fund
S&P 500
This Quarter Est. Return
+8.75%
1 Year Est. Return
+31.77%
3 Year Est. Return
+94.5%
5 Year Est. Return
+108.17%
10 Year Est. Return
+357.88%
AUM
$1.48B
AUM Growth
+$99M
Cap. Flow
-$1.88M
Cap. Flow %
-0.13%
Top 10 Hldgs %
43.59%
Holding
257
New
16
Increased
36
Reduced
85
Closed
31

Top Buys

Rank Stock Value
1
GPN icon
Global Payments
GPN
+$30.8M
2
CLVT icon
Clarivate
CLVT
+$16.5M
3
VMW
VMware, Inc
VMW
+$13.7M
4
USFD icon
US Foods
USFD
+$6.45M
5
CMBM
Cambium Networks
CMBM
+$4.29M

Sector Composition

Rank Sector Weight
1 Technology 27.01%
2 Financials 16.92%
3 Consumer Discretionary 13.53%
4 Healthcare 12.15%
5 Communication Services 10.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ORTX
226
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$30K ﹤0.01%
2,238
+698
+45% +$11.5K
ADUS icon
227
Addus HomeCare
ADUS
$2.16B
-2,598
Closed -$207K
ALB icon
228
Albemarle
ALB
$13.9B
-2,455
Closed -$538K
AMN icon
229
AMN Healthcare
AMN
$1.3B
-2,242
Closed -$257K
BWXT icon
230
BWX Technologies
BWXT
$15.5B
-5,640
Closed -$304K
CIGI icon
231
Colliers International
CIGI
$5.04B
-1,713
Closed -$219K
CW icon
232
Curtiss-Wright
CW
$26.7B
-2,529
Closed -$319K
EDU icon
233
New Oriental
EDU
$9.37B
-1,408
Closed -$29K
FCX icon
234
Freeport-McMoran
FCX
$90B
-9,810
Closed -$319K
FR icon
235
First Industrial Realty Trust
FR
$8.73B
-3,868
Closed -$201K
GILD icon
236
Gilead Sciences
GILD
$162B
-65,202
Closed -$4.55M
GMED icon
237
Globus Medical
GMED
$10.7B
-4,064
Closed -$311K
GNW icon
238
Genworth Financial
GNW
$3.76B
-28,000
Closed -$105K
IART icon
239
Integra LifeSciences
IART
$1.29B
-4,785
Closed -$328K
INTU icon
240
Intuit
INTU
$86.5B
-1,159
Closed -$625K
KINS icon
241
Kingstone Companies
KINS
$289M
-15,076
Closed -$100K
NRC icon
242
NRC Health Common Stock
NRC
$432M
-5,255
Closed -$222K
NVO
243
Novo Nordisk
NVO
$208B
-11,300
Closed -$542K
OKTA icon
244
Okta
OKTA
$24.7B
-2,843
Closed -$675K
OR icon
245
OR Royalties Inc
OR
$5.58B
-12,960
Closed -$146K
QLYS icon
246
Qualys
QLYS
$5.1B
-2,584
Closed -$288K
RGLD icon
247
Royal Gold
RGLD
$16.8B
-3,219
Closed -$307K
SHYF
248
DELISTED
The Shyft Group
SHYF
-7,305
Closed -$278K
SMG icon
249
ScottsMiracle-Gro
SMG
$3.82B
-1,973
Closed -$289K
SNAP icon
250
Snap
SNAP
$7.89B
-17,760
Closed -$1.31M

Similar funds

Cannell & Spears's Q4 2021 Portfolio in Review

As of Q4 2021, Cannell & Spears held 257 positions worth $1.48B, up 7.2% from $1.38B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Cannell & Spears's Q4 2021 filing shows 16 new, 36 increased, 85 reduced and 31 closed positions. Its largest new stake was Global Payments: 223,128 shares worth $30.2M. The largest sale was Fidelity National Information Services, an estimated $33.4M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 27% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Cannell & Spears's largest Q4 2021 buy was Global Payments: 223,128 shares worth $30.2M.
  • Cannell & Spears added most to VMware, Inc in Q4 2021, an estimated $13.7M increase.
  • Cannell & Spears's biggest Q4 2021 reduction was Fidelity National Information Services, cutting an estimated $33.4M.
  • Cannell & Spears fully exited Gilead Sciences in Q4 2021, selling an estimated $4.55M.
  • Cannell & Spears's ten largest holdings make up 44% of its $1.48B portfolio in Q4 2021.
  • Cannell & Spears opened 16 new positions and closed 31 in Q4 2021.
  • Cannell & Spears's portfolio value rose 7.2% quarter-over-quarter to $1.48B.

Based on Cannell & Spears's 13F filing for Q4 2021, filed 14 Feb 2022.